CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Effect of Denosumab on the Change of Osteoclast Precursors Compared to Zoledronate Treatment in Postmenopausal Women with Osteoporosis
Sung Hye Kong, Jung Hee Kim, Sang Wan Kim, Ae Jin Jeong, Song-Hee Lee, Sang-Kyu Ye, Chan Soo Shin
jbm. 2022;29(2):93-101.   Published online May 31, 2022
DOI: https://doi.org/10.11005/jbm.2022.29.2.93

Excel Download

Effect of Denosumab on the Change of Osteoclast Precursors Compared to Zoledronate Treatment in Postmenopausal Women with Osteoporosis
Journal of Bone Metabolism. 2022;29(2):93-101   Crossref logo
Link1 Link2 Link3

The effect of denosumab treatment on osteoclast precursor cells in postmenopausal osteoporosis
Bone Reports. 2020;13:100457   Crossref logo
Link1 Link2

The three-year effect of a single zoledronate infusion on bone mineral density and bone turnover markers following denosumab discontinuation in women with postmenopausal osteoporosis
Bone. 2020;138:115478   Crossref logo
Link1 Link2

Effect of Denosumab Treatment on the Risk of Fractures in Subgroups of Women With Postmenopausal Osteoporosis
Yearbook of Endocrinology. 2012;2012:201-203   Crossref logo
Link1 Link2

Update on Denosumab Treatment in Postmenopausal Women with Osteoporosis
Endocrinology and Metabolism. 2015;30(1):19   Crossref logo
Link1 Link2 Link3

Denosumab mid-term densitometric gain in postmenopausal osteoporosis women in clinical practice: comment on ‚ÄúVariability of denosumab densitometric response in postmenopausal osteoporosis‚ÄĚ
Rheumatology International. 2018;38(6):1161-1162   Crossref logo
Link1 Link2 Link3

Denosumab treatment in postmenopausal women with osteoporosis
The Lancet Diabetes & Endocrinology. 2017;5(10):767   Crossref logo
Link1 Link2

Compliance and discontinuation of denosumab treatment in postmenopausal Japanese women with primary osteoporosis or rheumatoid arthritis and osteoporosis
Osteoporosis and Sarcopenia. 2017;3(2):108-111   Crossref logo
Link1 Link2

Denosumab in the Treatment of Postmenopausal Women with Osteoporosis: Fracture Outcomes, BMD, and Morphological Assessment
Osteoporotic Fracture and Systemic Skeletal Disorders. 2021;377-388   Crossref logo
Link1

Denosumab treatment in postmenopausal women with osteoporosis
The Lancet Diabetes & Endocrinology. 2017;5(10):767-768   Crossref logo
Link1 Link2